Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy
- 14 October 2023
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 37 (1) , 100353
Abstract
No abstract availableKeywords
Funding Information
- Khalifa Bin Zayed Al Nahyan Foundation
- Bristol-Myers Squibb
- National Cancer Institute (/ NCI P30 CA016672)
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
This publication has 24 references indexed in Scilit:
- Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working groupLaboratory Investigation, 2015
- Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpointThe Lancet Oncology, 2014
- Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung CancersJournal of Thoracic Oncology, 2013
- Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcusVirchows Archiv, 2013
- Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant ChemotherapyJournal of Thoracic Oncology, 2013
- Long-term results in patients with pathological complete response after induction radiochemotherapy followed by surgery for locally advanced non-small-cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2013
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant ChemotherapyJournal of Thoracic Oncology, 2012
- Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission TomographyJournal of Clinical Oncology, 2008
- Grading of Tumor Regression in Non-small Cell Lung CancerChest, 2001
- Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessmentJournal of Cancer Research and Clinical Oncology, 1997